BUSINESS BRIEFING
- Share via
Times Wire Reports
The Alabama Supreme Court threw out jury decisions awarding the state more than $274 million from three pharmaceutical companies, ruling that they did not defraud the state in pricing Medicaid prescription drugs.
The court rescinded verdicts against AstraZeneca, Novartis and GlaxoSmithKline, which were accused by the state of fraudulently manipulating prices of drugs for Medicaid recipients.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
